Straumann Holding AG (XSWX:STMN) Accounts Payable & Accrued Expense: CHF690 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:STMN Straumann Holding AG XSWX:STMN
94 GF Score
Price CHF92.90
GF Value CHF125.52
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Straumann Holding AG Accounts Payable & Accrued Expense?

Straumann Holding AG XSWX:STMN +0.09% 94 Accounts Payable & Accrued Expense is CHF690 Mil as of Jun. 2026. GuruFocus rates XSWX:STMN with a GF Score™ of 94/100 and a GF Value™ of CHF125.52 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Straumann Holding AG's quarterly accounts payable & accrued expense declined from Jun. 2025 (CHF648 Mil) to Dec. 2025 (CHF370 Mil) but then increased from Dec. 2025 (CHF370 Mil) to Jun. 2026 (CHF690 Mil).

Straumann Holding AG's annual accounts payable & accrued expense declined from Dec. 2023 (CHF404 Mil) to Dec. 2024 (CHF379 Mil) and declined from Dec. 2024 (CHF379 Mil) to Dec. 2025 (CHF370 Mil).

Straumann Holding AG Accounts Payable & Accrued Expense Historical Data

* Premium members only.

The historical data trend for Straumann Holding AG's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Straumann Holding AG Accounts Payable & Accrued Expense Chart

Straumann Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 382.09 433.28 404.30 379.28 369.81

Straumann Holding AG Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 578.98 379.28 647.58 369.81 690.27
XSWX:STMN
94GF Score
Straumann Holding AG XSWX:STMN
Accounts Payable & Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Straumann Holding AG Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

What does a Accounts Payable & Accrued Expense of CHF690 Mil mean?
Straumann Holding AG (XSWX:STMN) has a Accounts Payable & Accrued Expense of CHF690 Mil as of Jun. 2026. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Straumann Holding AG and its competitors.
Is Straumann Holding AG's Accounts Payable & Accrued Expense too high?
Straumann Holding AG's current Accounts Payable & Accrued Expense is CHF690 Mil. Overall, Straumann Holding AG has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Straumann Holding AG's Accounts Payable & Accrued Expense compare to ISRG and BDX?
Straumann Holding AG's Accounts Payable & Accrued Expense of CHF690 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable & Accrued Expense for a Medical Devices & Instruments company?
A good Accounts Payable & Accrued Expense depends on the Medical Devices & Instruments industry context. However, Accounts Payable & Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable & Accrued Expense mean?
A high Accounts Payable & Accrued Expense can signal that a stock is expensive relative to its fundamentals. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Straumann Holding AG and its competitors. Straumann Holding AG's current Accounts Payable & Accrued Expense is CHF690 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Straumann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Straumann Holding AG (XSWX:STMN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF125.52, compared to a current price of CHF92.90 — trading 26% below its estimated fair value. The current Accounts Payable & Accrued Expense is CHF690 Mil. Straumann Holding AG's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable & Accrued Expense calculated?
Accounts Payable & Accrued Expense is calculated from a company's financial statements. For Straumann Holding AG (XSWX:STMN), the current Accounts Payable & Accrued Expense is CHF690 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Straumann Holding AG (XSWX:STMN) Overvalued in 2026?

Based on GuruFocus' analysis, Straumann Holding AG stock appears to be undervalued. The current stock price of CHF92.90 is trading 26% below its estimated GF Value™ of CHF125.52. GuruFocus considers Straumann Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:STMN:

  • Accounts Payable & Accrued Expense: CHF690 Mil
  • GF Value™: CHF125.52 vs. price of CHF92.90 (26% below fair value)
  • GF Score™: 94/100 with 3 warning signs

No single metric tells the full story. See the XSWX:STMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Straumann Holding AG Business Description

Address Peter Merian-Weg 12, Basel, CHE, 4002
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
94GF Score

Get the complete analysis for XSWX:STMN

Accounts Payable & Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF92.90
Price
CHF125.52
GF Value